Grabbe S, Steinert M, Mahnke K, Schwartz A, Luger T A, Schwarz T
Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the Skin, Department of Dermatology, University of Münster, Germany.
J Clin Invest. 1996 Sep 1;98(5):1158-64. doi: 10.1172/JCI118899.
Allergic contact dermatitis differs from most other immune reactions by its strict dose dependence during the elicitation phase. Moreover, almost all known contact allergens can also induce dose-dependent irritative dermatitis and in general only elicit allergic contact dermatitis in sensitized individuals when applied within a narrow dose range. Therefore, we hypothesized that elicitation of contact hypersensitivity (CHS) may require two signals, antigen-specific effector cell activation and a non-antigen-specific proinflammatory signal, both of which are provided by application of a sufficient dose of hapten. To dissociate these putative two signals, oxazolone-sensitized mice were ear challenged with a dose of the specific hapten which was too low to elicit CHS. At the same time, an unrelated hapten was applied in a conventional concentration to the same skin site. Whereas neither treatment alone elicited a significant CHS response, application of both compounds together resulted in a strong CHS response that was indistinguishable from that elicited by the full dose of the specific hapten. Upon coadministration of the irrelevant hapten, allergic contact dermatitis could be elicited even when the dose of the specific hapten was further reduced by a factor of 10(3). In contrast, a dose reduction of the irrelevant hapten by a factor of two resulted in the loss of the CRS response. These data indicate that non-antigen-specific effects of epicutaneously applied haptens significantly contribute to the elicitation of CHS responses and that the capacity of the hapten to evoke this proinflammatory stimulus rather than its antigenicity is responsible for the strict concentration dependence.
变应性接触性皮炎在激发阶段具有严格的剂量依赖性,这使其与大多数其他免疫反应不同。此外,几乎所有已知的接触性变应原也可诱发剂量依赖性刺激性皮炎,并且一般来说,只有在狭窄的剂量范围内应用时,才会在致敏个体中引发变应性接触性皮炎。因此,我们推测接触性超敏反应(CHS)的激发可能需要两个信号,即抗原特异性效应细胞活化和非抗原特异性促炎信号,这两个信号均由应用足够剂量的半抗原提供。为了分离这两个假定的信号,用低剂量的特定半抗原对恶唑酮致敏的小鼠耳部进行激发,该剂量不足以引发CHS。同时,将一种无关的半抗原以常规浓度应用于同一皮肤部位。单独使用这两种处理均未引发显著的CHS反应,但将两种化合物一起应用则导致强烈的CHS反应,这与用全剂量的特定半抗原引发的反应无法区分。在共同给予无关半抗原时,即使将特定半抗原的剂量进一步降低10³倍,也可引发变应性接触性皮炎。相反,将无关半抗原的剂量降低一半则导致CRS反应消失。这些数据表明,经皮应用半抗原的非抗原特异性效应显著促进了CHS反应的激发,并且半抗原引发这种促炎刺激的能力而非其抗原性是严格浓度依赖性的原因。